Purchase of an Illumina MiSeq i100 plus

Department of Health and Human Services

Forecast Overview

NAICS
541990
Performance end
5/2026

Purchase of Illumina MiSeq i100 plus which has the increased capability of sequencing pathogrens detected in seafood. This purchase is in support of our culture independent pathogen identification program and is needed for rapid long read sequencing methods development to support screening for pathogens in field environmental samples in real-time

Source

Source
HHS SBCX Forecast Export
Source file
Forecast.csv
Official source
Agency forecast source
Last verified
2026-08-31

Agency-published contact: · TBD@fda.hhs.gov

Related Federal Entities